Initial Statement of Beneficial Ownership (3)
January 13 2016 - 6:04AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Olson Charles V
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/5/2016
|
3. Issuer Name
and
Ticker or Trading Symbol
Anthera Pharmaceuticals Inc [ANTH]
|
(Last)
(First)
(Middle)
25801 INDUSTRIAL BLVD SUITE B
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
CHIEF TECHNOLOGY OFFICER /
|
(Street)
HAYWARD, CA 94545
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
7963
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock option (right to buy)
|
(1)
|
5/17/2023
|
Common Stock
|
43750
|
$4.88
|
D
|
|
Stock option (right to buy)
|
(2)
|
3/25/2024
|
Common Stock
|
922
|
$3.30
|
D
|
|
Stock option (right to buy)
|
(3)
|
7/29/2024
|
Common Stock
|
45000
|
$2.89
|
D
|
|
Stock option (right to buy)
|
(4)
|
12/30/2024
|
Common Stock
|
50000
|
$1.61
|
D
|
|
Stock option (right to buy)
|
(5)
|
9/17/2025
|
Common Stock
|
50000
|
$9.48
|
D
|
|
Stock option (right to buy)
|
(6)
|
1/7/2026
|
Common Stock
|
50000
|
$3.70
|
D
|
|
Explanation of Responses:
|
(
1)
|
This stock option vests annually over four years. The vesting commencement date is March 25, 2013. This stock option is fully vested on March 25, 2017 and will expire on May 17, 2023.
|
(
2)
|
This stock option is immediately vested on the grant date of March 25, 2014. This stock option will expire on March 25, 2024.
|
(
3)
|
This stock option vests monthly over four years. The vesting commencement date is July 1, 2014. This stock option is fully vested on July 1, 2018 and will expire on July 29, 2024.
|
(
4)
|
This stock option vests monthly over four years. The vesting commencement date is December 30, 2014. This stock option is fully vested on December 30, 2018 and will expire on December 30, 2024.
|
(
5)
|
This stock option vests monthly over four years. The vesting commencement date is December 30, 2014. This stock option is fully vested on December 30, 2018 and will expire on September 17, 2025.
|
(
6)
|
This stock option vests monthly over four years. The vesting commencement date is January 7, 2016. This stock option is fully vested on January 7, 2020 and will expire on January 7, 2026.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Olson Charles V
25801 INDUSTRIAL BLVD SUITE B
HAYWARD, CA 94545
|
|
|
CHIEF TECHNOLOGY OFFICER
|
|
Signatures
|
/s/ Charles V. Olson
|
|
1/13/2016
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Anthera Pharmaceuticals (CE) (USOTC:ANTH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anthera Pharmaceuticals (CE) (USOTC:ANTH)
Historical Stock Chart
From Apr 2023 to Apr 2024